What is the current Price Target for the Inhibrx Inc stock?

The average Inhibrx Inc target price is $15.00. This is 12.53% higher than the current stock price. 1 Analyst has issued a Inhibrx Inc price target 2026.

How high will the Inhibrx Inc stock rise?

No reliable answer can be given as to how high the Inhibrx Inc stock will rise. The performance of stocks, including the Inhibrx Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Inhibrx Inc stock today?

The performance of Inhibrx Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Inhibrx Inc stock fall?

The decline in Inhibrx Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Inhibrx Inc Forecast, price target & analysts

$12.76

4.31% today

Nasdaq, Apr 04, 08:48 pm CET

ISIN

US45720L1070

Symbol

INBX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Inhibrx Inc Target price 2025 - Analyst rating & recommendation

Inhibrx Inc Classifications & Recommendation:

Hold

100%

Inhibrx Inc Price Target

Target Price	$15.00
Price	$13.33
Potential	12.53% register free of charge
Number of Estimates	1

	1 Analyst has issued a Inhibrx Inc price target 2026. The average Inhibrx Inc target price is $15.00. This is 12.53% register free of charge higher than the current stock price.
	A rating was issued by 2 analysts: 0 Analysts recommend Inhibrx Inc to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Inhibrx Inc stock has an average upside potential 2026 of 12.53% register free of charge . Most analysts recommend the Inhibrx Inc stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	116.58	-10.37
	799.34%	108.90%
P/E		negative

1 Analysts have issued a Inhibrx Inc forecast for earnings per share. The average Inhibrx Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$116.58	799.34%
2025	$-10.37 108.90% Unlock
2026	$-7.47 27.97% Unlock

Current	0.11	101.58%
2025	-1.29 1,272.73% Unlock
2026	-1.78 37.98% Unlock

Inhibrx Inc...

Current Inhibrx Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Citizens Capital Markets	Locked ➜ Locked	Locked	Mar 18 2025
JMP Securities	Locked ➜ Locked	Locked	Jan 22 2025

Analyst Rating	Date
Locked Citizens Capital Markets: Locked ➜ Locked	Mar 18 2025
Locked JMP Securities: Locked ➜ Locked	Jan 22 2025

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now